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Abstract: Congenital Zika Syndrome (CZS) is caused by vertical transmission of Zika virus (ZIKV) to
the gestating human fetus. A subset of CZS microcephalic infants present with reduced otoacoustic
emissions; this test screens for hearing loss originating in the cochlea. This observation leads to
the question of whether mammalian cochlear tissues are susceptible to infection by ZIKV during
development. To address this question using a mouse model, the sensory cochlea was explanted at
proliferative, newly post-mitotic or maturing stages. ZIKV was added for the first 24 h and organs
cultured for up to 6 days to allow for cell differentiation. Results showed that ZIKV can robustly
infect proliferating sensory progenitors, as well as post-mitotic hair cells and supporting cells. Virus
neutralization using ZIKV-117 antibody blocked cochlear infection. AXL is a cell surface molecule
known to enhance the attachment of flavivirus to host cells. While Axl mRNA is widely expressed
in embryonic cochlear tissues susceptible to ZIKV infection, it is selectively downregulated in the
post-mitotic sensory organ by E15.5, even though these cells remain infectible. These findings may
offer insights into which target cells could potentially contribute to hearing loss resulting from fetal
exposure to ZIKV in humans.
Keywords: ZIKV; cochlea; hair cell; hearing
1. Introduction
Zika virus (ZIKV) is a flavivirus that received world-wide attention in 2015 when a
Brazilian outbreak revealed that ZIKV infection of pregnant women was linked to severe
birth defects in their newborns [1]. In the wake of the South American epidemic, Congenital
ZIKV Syndrome was defined by a set of pathologies that included severe microcephaly, thin
cerebral cortices with brain calcifications, eye defects, limb contractures and hypertonia as
major diagnostic criteria [2]. Hearing loss was linked to in utero ZIKV exposure in 12% of
114 infants evaluated during the second year of life [3]. A review of 27 studies that looked
for a positive correlation between fetal ZIKV exposure and congenital hearing loss shows
a wide range in this co-morbidity [4]. Non-invasive screening for hearing loss in infants
utilizes two methods that interrogate different parts of the auditory system (reviewed
by [5–7]). The auditory brainstem response (ABR) records neuronal responses to sound
stimuli and provides threshold readouts for neurons from the auditory nerve through to
the midbrain. Otoacoustic emission (OAE) can identify defects in the peripheral auditory
system, particularly in the outer hair cells of the organ of Corti (the sensory organ for
hearing in a mammalian inner ear). Outer hair cell motility can transmit energy from the
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cochlea through the middle ear to vibrate the tympanic membrane. This leads to sounds
being emitted from the ear that are detected by sensitive microphones placed in the ear
canal. Thus, an ear presenting with weak or absent OAEs is suspected to have defective
or missing outer hair cells as an underlying cause [8]. In the context of ZIKV infection,
this raises the question of whether the virus can cause hair cell pathologies as a sequela of
direct infection of these primary sensory receptors.
The susceptibility of the inner ear tissues to ZIKV was recently reported for two
vertebrate animal models: chicken embryos [9] and adult mice with compromised immune
systems [10]. In the chicken embryo, our group found that the inner ear could be infected by
direct delivery of virus into the fluid compartment of the inner ear. The outcome from this
route of infection varied for different cell types (such as neurons, hair cells and semicircular
canals). For instance, the auditory ganglion was most susceptible to infection during the
first week in ovo, when inner ear progenitors are mitotically active, and responded with
an increase of cell death and major shrinkage. In contrast, the sensory organ of hearing
was more susceptible to ZIKV during the second week in ovo, during hair cell maturation,
but this infection did not generate overt pathology over several days. This suggests that
the different inner ear cell types may have specific critical periods of susceptibility and
sensitivity to ZIKV, although until now this has not been tested in an embryonic mammalian
inner ear. In the 5−6-week-old immunocompromised mouse, systemic ZIKV delivery
resulted in infection of the inner ears as well as subsequent histological pathologies at
9 days post-infection [10]. Cellular damage (swelling, intracellular vacuoles, translocation
of the nucleus and/or apical surface blebbing) was observed in the sensory epithelia (both
auditory and vestibular) or in the spiral ganglion, whose axons bundle to form the auditory
nerve. Other regions of the cochlea, such as the stria vascularis, displayed epithelial
detachment. Our current study aimed to determine if the mammalian cochlea is equally
vulnerable to ZIKV during its development. In view of reports that mitotically active
neural progenitors are more susceptible to ZIKV infection than post-mitotic neurons [11],
this study examined stages of cochlear development that spanned the time from mitotic
to postmitotic stages. These experiments can guide neonatal diagnostics by establishing a
timeline of susceptibility of the cochlear duct.
Recent studies have identified antibodies directed against ZIKV that can neutralize its
ability to infect mammalian host cells [12,13], with the goal toward understanding binding
of the virus, as well as seeking potential therapeutic agents to combat ZIKV spread [14,15].
In this study, we also explore the possibility of neutralizing active ZIKV infection of the
cochlea with a known ZIKV-specific antibody, ZIKV-117.
An active area of investigation is the search for cellular receptors and mechanisms
used by ZIKV to attach to host cells, gain entry into the cell and initiate a productive
infection. AXL is a member of the TYRO3/AXL/MER (TAM) family of cell-surface proteins
that can promote ZIKV entry/attachment in some human and mouse cells (reviewed
by [16]). While AXL is not strictly required for ZIKV to initiate a productive infection in
mice, its tissue distribution can sometimes be correlated with variable sensitivity to ZIKV.
Here, we also look at Axl expression as a function of developmental stage in the embryonic
and neonatal mouse cochlea, to seek a correlation between Axl localization and tissue
susceptibility to ZIKV.
2. Materials and Methods
2.1. Mice
Swiss Webster mice (Envigo, Inc., Indianapolis, IN, USA) were housed and bred in
accordance with the Institutional Animal Care and Use Committee (IACUC) at Purdue
University and The Jackson Laboratory (ACUC). Veterinary care and oversight of the
animal facilities and husbandry practices were provided at The Jackson Laboratory and
the Laboratory Animal Program (LAP) at Purdue University.
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2.2. Collection of Embryos and Neonatal Pups
Mice were timed mated and the date at which a vaginal plug was observed was noted
as embryonic day 0.5 (E0.5). To harvest embryos of defined ages (E12.5–E18.5), pregnant
mice were euthanized via CO2 inhalation, followed by secondary cervical dislocation.
Embryos were extracted from the uterus and placed in cold Hank’s Balanced Salt Solution
(HBSS). The developmental age of the litter was determined via Theiler staging: http:
//www.emouseatlas.org/emap/ema/theiler_stages/downloads/theiler2.pdf (accessed 1
June 2016). Embryos were then decapitated. Postnatal day 2 (P2) pups were anesthetized
via hypothermia on ice, followed by rapid decapitation. The heads from embryos and pups
were either dissected to isolate the cochleae for organ culture or they were placed into 4%
paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for histological processing.
2.3. Cochlear Cultures
These experiments were started with ZIKV virus stocks of the Asian lineage
(H/PF/2013) titered at 8.7–9.6 × 107 plaque-forming units per milliliter (PFU/mL).
These were aliquoted into smaller volumes to reduce freeze-thaw cycles for the subse-
quent experiments. Aliquots were stored at −80 ◦C and thawed on ice immediately
before adding 5 microliters (~5 × 105 PFU) to each filter. Approximately 2 years later, the
titers had dropped to 1.5–1.7 × 107 PFU/mL. Thereafter, to compensate for these lower
titers, we increased the inoculum to 8 microliters (~105 PFU) per filter for experiments
conducted over the final year of the study. Most of these latter experiments were included
in Experimental Group B described below.
Cochleae from staged embryos were dissected in HBSS and cultured with their apical
surfaces up by placing on Collagen/Matrigel-coated Millicell culture inserts (Invitrogen,
Inc.) at 37 ◦C in a 4% CO2 incubator as described [17]. For cultures initiated on E12.5, the
cochlear duct was usually not opened, as we had determined that virus could adequately
diffuse into these smaller ducts. For cultures started on E15.5 or P2, the cochlear duct was
deliberately opened to expose the apical surface of the sensory epithelium. Two to four
cochleae (with or without the saccular macula attached) were placed on each filter.
After culturing for 4–6 h to allow the explants to adhere, ZIKV (1–5 × 105 PFU) was
dripped onto the top of each filter and they were returned to the incubator. After 24−48 h,
the medium was replaced and cochleae were incubated for several additional days to allow
sensory hair cells and supporting cells to begin to differentiate, recognizing that ZIKV
might continue to spread during this time window. Approximately equal numbers of
cochleae were untreated to serve as negative controls. Cochleae were cultured for either 3
or 6 days in vitro (DIV).
Experimental Group A was used for determination of cell types that were infected
with ZIKV and cultured for 6 DIV. This included experiments initiated at E12.5 (n = 3
experiments), E15.5 (n = 4) and P2 (n = 3) with ZIKV added for 24 h. For three additional ex-
periments, virus was left in the cultures for 48 h before washout (Supplementary Table S1).
In total, 93 organs, including controls, were cultured and evaluated in Experimental
Group A.
Experimental Group B was used to evaluate cell death in control and ZIKV-exposure
organs. This group included 6 experiments, with a set of E15.5 plus 3 DIV (n = 4) used for
quantitative analysis of active Caspase-3. Experimental Group B comprised 41 organs.
Experimental Group C was used for antibody blocking experiments using ZIKA-117
that neutralizes Zika virus replication [12]. To make sure the neutralizing antibody had full
access to the sensory organs at the time of explantation on E12.5, the roofs of the ducts were
removed prior to being placed on inserts. Selected explants were pre-incubated with 5 µL
of ZIKV-117 antibody (8.2 µg/µL). At 6 h, ZIKV was added directly on top of the explants
and both the antibody and virus were washed out after 24 h. A total of 19 cochleae were
cultured for 6 DIV and evaluated for Experimental Group C.
For all 3 experimental groups, the cochleae were fixed with 4% PFA in PBS and
processed for immunofluorescence as previously described [18]. The data presented here are
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based on 21 separate culture experiments (i.e., set up on different days) totaling 153 explants
(Supplementary Table S1).
2.4. Histology
Primary antibodies were used to detect double-stranded RNA, dsRNA (1:500; mouse
IgG2a, J2 monoclonal, SCICONS #10010200), active Caspase-3 (1:400; rabbit IgG; BD Bio-
sciences #559565), Sox2 (1:100–1:250 goat polyclonal, R&D Systems #AF2018) and myosinVI
(1:200; rabbit polyclonal; Proteus Biosciences #25-6791). Alexa Fluor® secondary antibodies
(1:500, donkey or goat polyclonal; Invitrogen) of 488 (green), 568 (red) or 647 (far red)
varieties were chosen as appropriate to allow for triple-labeling.
For in situ hybridization, heads were fixed overnight in RNase-free 4% PFA in PBS,
moved through graded sucrose solutions (10%, 20%, 30% in PBS) for several hours to
overnight, covered with TFM tissue freezing medium and frozen on a metal block cooled
with liquid nitrogen. They were stored long-term at −80 ◦C. Cryostat sections of 12–25 mi-
cron thickness were placed on slides and stored at −20 ◦C. Sections were processed for
in situ hybridization using an RNAscope® probe for mouse Axl with the RNAscope®
2.5 HD Assay-Red kit following the instructions of the manufacturer (ACD). This included
a boiling step and protease treatment for antigen retrieval before adding the probe. Pos-
itive signals are pink/magenta dots when viewed with brightfield or bright red when
viewed using a fluorescence microscope. Some slides were counterstained with 50% Gill’s
Hemotoxylin I. Other slides were post-processed for immunofluorescent co-labeling of
hair cells by treating with blocking solution of 5% horse serum in PBS and incubating with
rabbit anti-myosinVI as the primary antibody and donkey anti-rabbit AlexaFluor 488 as
the secondary antibody.
2.5. Microscopy and Evaluating Infection
Samples were screened and photographed with a Spot CMOS camera attached to a
Nikon Eclipse E800 microscope. Selected samples were imaged using 10X 20X and/or 60X
objectives with a Nikon confocal microscope (Purdue University) or a Zeiss LSM800 confo-
cal microscope (The Jackson Labroatory). Typically, the entire cochlea was reconstructed
from Z-stacks taken at a lower power, and then 3–6 Z-stacks were taken with the 60X
oil-immersion objective, roughly equally spaced along the length of the cochlea from base
to apex. All Z-projections were created using the maximum intensity algorithm in NIH
ImageJ. Images were processed and analyzed with NIH ImageJ and any additional image
enhancement (brightness increase) was done with Adobe Photoshop and is indicated in
the figure legend.
Analysis of cell infection with ZIKV was conducted via a careful evaluation of confocal
image stacks taken with a 60X lens. After merging the colors for each antibody label into
single slices of the Z-stack, we scrolled through the Z-stack to detect dsRNA-positive pixels.
An obvious cluster of positive pixels was used to indicate infected cell(s). To determine that
a hair cell was indeed infected, and not simply surrounded by the processes of infected
supporting cells, we required overlap of anti-dsRNA and anti-myosinVI signals (the latter
distributed throughout the hair cell cytoplasm). To determine that supporting cells were
infected with ZIKV, we looked for clustered dsRNA-positive pixels within the supporting
cell layer; this layer was marked by dense, small nuclei labeled with an anti-Sox2 antibody
to the transcription factor SOX2. Clustered foci of anti-dsRNA in the supporting cell
layer were considered evidence of infection of this cell type, because no other cells occupy
this layer. Similar criteria were used to judge ZIKV infection of cells within the GER, a
domain that was also Sox2-positive. Mesenchymal cells were judged to be infected when
we saw larger clusters of dsRNA-positive pixels located beneath the epithelial layers of the
cochlear duct. These judgements of positive infection were always made by comparison
to control (uninfected) cochleae from the same experimental batch, which were fixed and
immunolabeled in parallel and imaged within a few days of each other. The control cultures
were usually devoid of larger anti-dsRNA puncta that marks viral replication. Some control
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batches showed diffuse speckled labeling of the surface of the culture, but this was readily
distinguished from a more clustered distribution of a larger puncta characteristic of cellular
infection. The former was classified as a staining artifact.
2.6. Image Analysis of Cell Death
Confocal image stacks, captured with a 60X objective, were prepared from the base,
middle and apical parts of each cochlea. In each stack, we selected a sample depth of
20 slices to include the Sox2-positive supporting cell region. This was collapsed into a
maximum intensity Z-projection. Separate region of interest (ROI) outlines were made
for the organ of Corti and the GER, which can be recognized by differences in the size
and density of the Sox2-labeled cell nuclei. These outlines were saved in the ROI manager
for subsequent use. Each Z-projection was then split into three color channels, to isolate
the active Caspase-3 (red) signal. The red channel was despeckled three times and auto-
thresholded using the “Max Entropy” algorithm with the threshold set to 50–255. This was
empirically judged to most closely resemble the clumped caspase signals observed in the
original Z-projection, while discarding background pixels. These images were quantified in
two ways. In the first, we calculated the proportion of each sample area that was occupied
by caspase-positive pixels. A macro was created and run to generate area measurements
for the ROIs and to quantify the caspase-positive areas within each ROI as a fraction of
the total ROI area. In the second method, a macro was created to count the number of
separate caspase foci in each ROI, to approximate the number of caspase-positive cells. For
both methods, the values from individual stacks from the same cochlea were averaged.
Neither method revealed significant differences between the controls and ZIKV cochleae,
with separate statistical comparisons done for the organ of Corti and the GER (Graphpad
Prism 5 software, one-tailed t-test, all p values > 0.1).
3. Results
3.1. ZIKV Infects Both Prosensory (Mitotic) Cells and Post-Mitotic Sensory Cells in Cochlear
Organ Cultures
The mouse cochlea undergoes major morphogenetic and cellular changes that could
affect its susceptibility to ZIKV as development progresses. To assess this possibility, we
isolated cochleae from mouse embryos at three key time points (E12.5, E15.5 and P2) that
span from the proliferative to the mid-differentiation stages of sensory hair cells. To orient
the reader to cochlear morphology at a time equivalent to E12.5 plus 6 DIV, we show a
cross-section through a cochlear duct fixed and stained in situ at E18.5 (Figure 1A). The
organ of Corti is a narrow domain present on the floor of the cochlear duct and is occupied
by inner and outer hair cells and their underlying supporting cells. The acellular tympanic
membrane spans across the sensory epithelium. The organ of Corti is flanked by the GER on
one side and the outer sulcus on the other side (located towards the outside of the cochlear
spiral). Mesenchymal cells of the basilar membrane reside beneath the organ of Corti. The
epithelial cells derived from the roof of the cochlear duct will associate with adjacent cells
to form two specialized structures: Reissner’s membrane and the stria vascularis.
Explants were cultured and treated with ZIKV as described in Materials and Methods.
After 6 DIV, infected cells were detected using an antibody directed against dsRNA. Young
hair cells express myosin-6, and both supporting cells of the organ of Corti as well as
the cells of the GER express SOX2. Addition of ZIKV at all three ages resulted in robust
infection of the cochleae and the surrounding mesenchyme. As a general observation, ZIKV
infection was evident within each of the major cell types and domains of the epithelium, as
compared to controls from the same experiment that were processed in parallel. Exemplar
specimens are shown for cochlear cultures established from an E12.5 mouse and cultured
for 6 DIV (Figure 1B). The control cochlea (Figure 1C) has only background labeling with
the dsRNA antibody. For the ZIKV specimen (Figure 1D), virus was washed out with a
media change 48 h after it was added to the culture. Infected hair cells were defined by
having large dsRNA-positive puncta that overlapped with myosin-6 immunoreactivity in
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optical slices captured with a 60X lens. See Methods Section 2.5 for further criteria used to
identify virus-infected cells of different types. Using established criteria, virus was localized
to cells throughout the cochlear epithelium and the surrounding tissues (both epithelial
and mesenchymal). Mesenchymal cells were often the most intensely immunoreactive
for dsRNA and were readily apparent at low power (Figure 1D). When included in the
cultures, the epithelial roof of the cochlear duct and its associated mesenchyme were also
found to be infected. Within the cochlear duct, infected cells were observed in the GER.
ZIKV dsRNA was detected in both inner and outer hair cells and in the SOX2-postive
supporting layer located beneath the hair cells. Confocal image slices taken at the level of
the hair cells (Figure 1(D1)) or at the level of the supporting cells and the GER (Figure 1(D2))
allow for separate confirmation of dsRNA within these cell types.




Figure 1. Cochlear architecture shown in situ on E18.5 and after E12.5 explants were cultured for 6 days. (A) A histological 
section through an E18.5 cochlea stained with hematoxylin and eosin. The epithelium of the cochlear duct is outlined with 
a dashed white line. The floor of the cochlear duct includes cells of the organ of Corti (oC) and the greater epithelial ridge 
(GER). In this turn of the cochlea, medial is towards the left and lateral is towards the right. Scale bar = 100 microns. (B) 
Experimental design for panels C and D depicting explants prepared on E12.5, with a green bar for a 48 h window, 
beginning 4–6 h after the culture is initiated, to indicate with or without the addition of ZIKV (+Z). After fixation (black 
arrowhead) at 6 DIV, triple immunostaining was done with dsRNA, myo6 and Sox2 antibodies. (C,D) Maximum-intensity 
Z-projections of cochleae immunolabeled as indicated. Asterisk in C1 denotes an area of background dsRNA labeling on 
the surface of the tissue. High power views of the boxed areas are shown in the adjacent two panels, focused on either the 
hair cell layer (C1,D1) or the supporting cell layer (C2 and D2) by including only 10 consecutive optical slices. White 
arrowhead depicts a dsRNA-positive outer hair cell. Scale bars = 200 microns for low power images (panels C,D) and 20 
microns for high power images. Abbreviations: a, apex of cochlea; b, base of cochlea; bm, basilar membrane; E, embryonic 
day; GER, greater epithelial ridge; ihc, inner hair cells; mes, mesenchyme; oC, organ of Corti; ohc, outer hair cells; os, outer 
sulcus; Rm, Reissner’s membrane; sac, saccular macula; scl, supporting cell layer; sm, scala media; SpG, spiral ganglion; 
stria, stria vascularis; tm, tectorial membrane; Z, ZIKV. 
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i re . l it ct re s o n in sit 8.5 fter 2.5 la ts ere cultured for 6 days. ( ) ist l ical
secti 18.5 cochlea stained with hematoxylin and eosin. The epithelium of the cochlear duct is outlined
with a dashed white line. The floor of the cochlear duct includes cells of the organ of Corti (oC) and the greater epithelial
ridge (GER). In this turn of the cochlea, medial is towards the left and lateral is towards the right. Scale bar = 100 microns.
(B) Experimental design for panels C and D depicting explants prepared on E12.5, with a green bar for a 48 h window,
beginning 4–6 h after the culture is initiated, to indicate with or without the addition of ZIKV ( +Z). After fixation (black
arrowhead) at 6 DIV, triple immunostaining was done with dsRNA, myo6 and Sox2 antibodies. (C,D) Maximum-intensity
Z-projections of cochleae immunolabeled as indicated. Asterisk in C1 denotes an area of background dsRNA labeling on the
surface of the tissue. High power views of the boxed areas are shown in the adjacent two panels, focused on either the hair
cell layer (C1,D1) or the supporting cell layer (C2,D2) by including only 10 consecutive optical slices. White arrowhead
depicts a dsRNA- sitive out r hair c ll. Scale bars = 200 microns for low power images (panels C,D) and 20 microns for
high power images. Abbreviations: a, apex of cochlea; b, base of cochlea; bm, basilar membrane; E, embryonic day; GER,
greater epithelial ridge; ihc, inner hair cells; mes, mesenchyme; oC, organ of Corti; ohc, outer hair cells; os, outer sulcus; Rm,
Reissner’s membrane; sac, saccular macula; scl, supporting cell layer; sm, scala media; SpG, spiral ganglion; stria, stria
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3.1.1. E12.5 Plus 6 ays In Vitro
One purpose of this study was to assess the susceptibility of cochlear cells to viral
infection at different developmental stages. To narrow the time window of potential
infection, we reduced the duration of ZIKV addition to 24 h, beginning on the day the
explant was placed in vitro. Mouse cochlear cultures were initiated on E12.5. At this time,
the cochlear duct is lined with an actively mitotic epithelium [19]. At a histological level in
situ, the E12.5 cochlear epithelium is thicker on the floor of the duct (the prosensory side)
and thinner on the roof of the duct that will develop into specific non-sensory cochlear
tissues. The duct epithelium rests on a basal lamina and is surrounded by mesenchymal
cells. These mesenchymal were included in the cultures.
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ZIKV was added to the E12.5 cultures after 4–6 h in vitro, washed out 24 h later,
and the cells were allowed to differentiate for a total of 6 DIV, as indicated schematically
(Figure 2A). Controls lacked the puncta of dsRNA labeling that characterized infected cells
(Figure 2(A1,A2)). The same cell types (hair cells, supporting cells, GER and mesenchyme)
labeled for dsRNA after this shorter ZIKV incubation time (Figure 2(A3,A4)), as was
observed with a 48 h incubation. This figure is representative of 10 cochleae infected with
ZIKV across 3 independent experiments, with 9 control explants processed in parallel.
3.1.2. E15.5 Plus 6 Days In Vitro
In the intact animal, the prosensory domain of the mouse begins to pull out of division
between E13 and E14, with the apex exiting the cell cycle slightly in advance of the base [19].
By E14, over 80% of the cells in the future organ of Corti are no longer dividing, which
demarcates a so-called “zone of non-proliferation” [20]. The cessation of proliferation
in the organ of Corti primordium is under the control of the cyclin-dependent kinase
inhibitor 1b, Cdkn1b (also known as p27Kip1) [20]. Most of the remaining cells of the
duct floor continue to proliferate for several more days. At the time E15.5 cultures were
initiated and infected with ZIKV, the zone of non-proliferation that marks the future organ
of Corti is well established. Thus, this time point was chosen to determine whether post-
mitotic sensory cells are susceptible to ZIKV infection. Four independent experiments
were conducted, with a total of 38 organs (20 controls and 18 ZIKV) analyzed. Similar
to Section 3.1.1, virus was added on the first day of culture and washed out after 24 h
(Figure 2B). When processed after 6 DIV, the control cultures were devoid of punctate
labeling with anti-dsRNA (Figure 2(B1,B2)). In total, all but one of the 18 organs exposed
to ZIKV displayed well-infected hair cells (Figure 2(B3)). Nearly all of these ZIKV-treated
specimens also showed infection in the supporting cell layer and in the GER (Figure 2(B4)).
3.1.3. P2 Plus 6 Days In Vitro
Cultures initiated at P2 have already established a single row of inner hair cells and
3–4 rows of outer hair cells throughout the apical-basal longitudinal axis of the cochlea. All
hair cells and supporting cells are post-mitotic at this time [19]. ZIKV was added for a 24 h
window at the start of these cultures. The experimental conditions for P2 plus 6 DIV are
shown in Figure 2C. Controls showed little to no dsRNA labeling (Figure 2(C1,C2)). The
addition of ZIKV showed that postnatal hair cells, supporting cells and GER cells are still
susceptible to infection (Figure 2(C3,C4)). The amount of infection appears lower than for
the embryonic explants, both in the amount of dsRNA-positive signal per infected cell and
in the number of infected cells. This is apparent for both hair cells and supporting cells.
In summary, the cells of the organ of Corti, the GER and the adjacent tissues are
susceptible to ZIKV at E12.5, E15.5 and P2. No consistent phenotypic abnormalities were
present in infected cells, and the organ’s overall morphology was not obviously different
between controls and ZIKV-treated samples at any of the ages tested.
3.2. ZIKV Infection Does Not Induce Extensive Cell Death in the Cochlear Epithelium
Cochlear cultures actively infected with ZIKV had normal tissue morphology up
to 6 days later. Swollen cells characteristic of necrosis or cell fragments associated with
apoptosis were observed rather infrequently. Because ZIKV can lead to increases in cell
death in other cell types, including both embryonic and adult neural progenitors [11,21,22],
we evaluated infected cultures for possible changes in cell death using an antibody to active
Caspase-3. Evaluation of each cochlea was done by creating confocal image stacks using a
60X objective and deliberately sampling from 3–5 regions along the apical-basal length of
the cochlea. Three conditions were evaluated: E12.5 plus 3 DIV (2 controls, 4 ZIKV), E15.5
plus 6 DIV (2 controls, 3 ZIKV) and E15.5 plus 3 DIV (16 controls, 15 ZIV).




Figure 2. Cochlear cultures were infected with ZIKV at (A) E12.5, (B) E15.5 and (C) P2 and processed 
after 6 DIV. Images are Z-projections from 10 adjacent optical slices through either the hair cell layer 
(left columns) or the supporting cell layers (right columns). The myo6 and Sox2 signals for panel C 
were brightened to improve the contrast. Scale bar = 20 microns. Abbreviation: DIV, days in vitro; 
P, postnatal day; all other abbreviations as in Figure 1 legend. 
  
Figure 2. Cochlear cultures were infected with ZIKV at (A) E12.5, (B) E15.5 and (C) P2 and proce sed
after 6 DIV. Images are Z-projections from 10 adjacent optical slices through either the hair cell layer
(left columns) or the supporting cell layers (right columns). The myo6 and Sox2 signals for panel
(C) were brightened to improve the contrast. Scale bar = 20 microns. Abbreviation: DIV, days in vitro;
P, postnatal day; all other abbreviations as in Figure 1 legend.
Z-projections of images from a pair of cochleae are shown from the E12.5 plus 3 DIV
experiment (Figure 3A). The control (untreated with ZIKV) showed caspase labeling in
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the organ of Corti (Figure 3(A1), arrow). Figure 3(A2) presents an exceptionally well-
infected ZIKV sample that demonstrates three findings: (1) the overwhelming majority
of dsRNA-positive cells did not co-label with active Caspase-3; (2) caspase-positive cells
were relatively sparse in the cochlea and typically were dsRNA-negative; and (3) on rare
occasions we observed cells double-positive for dsRNA and active Caspase-3 (Figure 3(A2),
open arrowhead). This image stack has caspase-positive cells in both the organ of Corti
and in the GER.
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The E15.5 plus 3 DIV experiments were quantified for active Caspase-3 foci, with
separate analysis done on the GER and the organ of Corti. SOX2 immunolabeling was used
to locate these regions. (Figure 3B). Both control and ZIKV explants were observed to have
a few caspase-positive foci in the sampled regions (Figure 3(B1,B2)). The number of such
foci per image stack was not statistically different between controls and ZIKV samples
(Figure 3C). It should be noted that these experiments were conducted with a virus stock
whose titer had dropped almost 10-fold over time, such that only 50% (n = 26/53) of the
Viruses 2021, 13, 1823 10 of 17
regions selected to image had dsRNA-positive cells within the SOX2 expression domains.
It is possible that the results may have been different if we were able to obtain higher levels
of infection. Despite this caveat, there was limited spatial overlap between cells expressing
dsRNA (actively ZIKV-infected) and cells labeled for active Caspase-3. Thus, we found
no evidence for an increase in cell death in cochleae after 3 days of culture in the presence
of ZIKV.
3.3. ZIKV Infection of the Cochlea Is Blocked by Preincubation with a Neutralizing Antibody
A particularly potent neutralizing antibody is ZIKV-117, whose binding to the ZIKV
surface has been studied using high-resolution structural biology approaches [23,24]. The
presence of the antibody can block the virus from infecting host cells in vitro [12]. We tested
this effect on mouse cochlear explants. Three conditions were tested in cultures established
at E12.5. In the first condition (control, n = 7), explants were untreated (Figure 4A). These
showed very little signal for dsRNA (Figure 4(A1,A1a)). In the second condition (ZIKV,
n = 6), explants were given 24 h of exposure to ZIKV and then given a media change
(Figure 4B). These were labeled with dsRNA (Figure 4(B1,B1a), n = 6). In the third condition
(AB + ZIKV, n = 6), explants were treated with ZIKV-117 antibody for 6 h to allow for
penetration into the duct, and then ZIKV was added. A media change 24 h later was used
to remove the antibody and the virus (Figure 4C). All explants were allowed to develop
for a total of 6 DIV. Processing the tissue to detect dsRNA and cell types showed almost a
total block of ZIKV infection when added to the cultures in the presence of the neutralizing
antibody (Figure 4(C1,C1a)).
3.4. Axl Transcripts Are Expressed in Many Tissues of the Developing Inner Ear
The cochlear tissue tropism for ZIKV infectivity was quite ubiquitous at the stages
examined, suggesting that the host cell receptor(s) used by the virus to gain entry into
these cells is likewise broadly distributed within the cochlea. Although the full range of
cellular receptors and attachment factors used by ZIKV is still being investigated, there is
evidence that the surface protein AXL promotes ZIKV entry into mammalian cells using
both gain-of-function and loss-of-function approaches [25–29]. On the other hand, it is
not strictly required for ZIKV susceptibility (reviewed by [16]). AXL is a member of the
TAM family of receptor tyrosine kinases. TAM receptors bind secreted ligands to sense
phosphotidylserine on membranes of apoptotic cells and facilitate their clearance. TAMs
also play a key role in attenuating innate immunity after an inflammatory response to
pathogens has been activated (reviewed by [30]).
Even if there is redundancy among ZIKV receptors/attachment factors, it can still
be useful to map their expression in permissive organs, such as the cochlea. RNA-seq
experiments indicate that transcripts encoding all 3 TAM proteins (TYRO3, AXL and MER)
are expressed in embryonic and neonatal cochleae. They are differentially expressed in
hair cells and supporting cells, and their levels vary with the stage of development (see
www.umgear.org, accessed 15 July 2021 [31–34]). However, these methods lack spatial and
temporal resolution.
In this study, we examined the distribution of Axl transcripts in the developing mouse
cochlea at the histological level at 6 time points (E12.5, E13.5, E15.5, E17.5, E18.5, P2) by
sampling 2–5 embryos per age. This spans the time window of the culture experiments. In
situ hybridization on cryostat sections of mouse heads was used to localize Axl at stages
when ZIKV readily infects the cochlea in vitro. The earliest timepoint examined was E12.5,
which showed broad but weak Axl labeling throughout the epithelium of the cochlear
duct, including both its thicker prosensory domain and the thinner non-sensory roof of the
duct (Figure 5A). The mesenchyme surrounding the inner ear also expressed Axl, whereas
expression in the spiral ganglion was scattered and even weaker by comparison (data
not shown). At E13.5, Axl signal intensity in the cochlea remained weak and generally
resembled E12.5 in its tissue distribution (data not shown).
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By E15.5, the floor of the cochlear duct showed a reproducible gap in Axl expression
(Figure 5B, black arrowhead). This gap was associated with the position of the developing
organ of Corti, as indicated by double-staining with antibody to myosin-6 (shown at E18.5
in Figure 5(C1)). Both inner and outer hair cells and their associated supporting cells were
located within the gap. We used confocal imaging of E18.5 specimens to address whether
or not individual hair cells of the organ of Corti retained any Axl signal (Figure 5C), since
the cell culture data showed they were still susceptible to ZIKV beyond this age. Indeed,
selected examples of both hair cell types presented with spatial overlap of Axl-positive
puncta and the cytoplasmic marker, myosin-6. This was more frequently observed for inner
hair cells (Figure 5(C1a)). In contrast, some inner hair cells and the majority of outer hair
cells did not appear to have detectable levels of Axl transcripts. Turning our attention to the
supporting cell layer located beneath the hair cells, we observed a scattering of Axl-positive
puncta here. The single row of supporting cells associated with inner hair cells that will
mature into inner phalangeal cells were reliably Axl-positive. Nonetheless, the observation
of lower levels of Axl specifically within the organ of Corti was evident in all specimens
examined from E15.5 through P2.




Figure 4. ZIKV infection of E12.5 cochlear explants is effectively neutralized by the ZIKV-117 
antibody. Top row shows the experimental conditions, with exemplar cochleae for each condition 
shown at low power in the middle row. The regions outlined by white boxes are shown at higher 
power in the panels of the bottom row. The high-power images are Z-projections combined across 
58 optical slices to include both hair cell and supporting cell layers. White arrow points to an infected 
hair cell. Scale bars = 200 microns for low power (middle row) and 50 microns for high power 
(bottom row). Abbreviations: DIV, days in vitro. All other abbreviations see Figure 1 legend. 
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i r 4. ZIKV infection of E12.5 cochlear explants is effectively neutralized by the ZIKV-117 antibody.
Top row shows the experimental conditions, with exemplar cochleae for each condition shown at
low power in the middle row. The regions outlined by white boxes are shown at higher power in
the panels of the bottom row. The high-power images are Z-projections combined across 58 optical
slices to include both hair cell and supporting cell layers. White arrow points to an infected hair cell.
Scale bars = 200 microns for low power (middle row) and 50 microns for high power (bottom row).
Abbreviations: DIV, days in vitro. All other abbreviations see Figure 1 legend.
Viruses 2021, 13, 1823 12 of 17
Viruses 2021, 13, x FOR PEER REVIEW 12 of 17 
 
 
www.umgear.org, accessed 15 July 2021 [31–34]). However, these methods lack spatial 
and temporal resolution. 
In this study, we examined the distribution of Axl transcripts in the developing 
mouse cochlea at the histological level at 6 time points (E12.5, E13.5, E15.5, E17.5, E18.5, 
P2) by sampling 2–5 embryos per age. This spans the time window of the culture 
experiments. In situ hybridization on cryostat sections of mouse heads was used to 
localize Axl at stages when ZIKV readily infects the cochlea in vitro. The earliest timepoint 
examined was E12.5, which showed broad but weak Axl labeling throughout the 
epithelium of the cochlear duct, including both its thicker prosensory domain and the 
thinner non-sensory roof of the duct (Figure 5A). The mesenchyme surrounding the inner 
ear also expressed Axl, whereas expression in the spiral ganglion was scattered and even 
weaker by comparison (data not shown). At E13.5, Axl signal intensity in the cochlea 
remained weak and generally resembled E12.5 in its tissue distribution (data not shown). 
 
Figure 5. Axl is expressed in the embryonic mouse cochlea. RNAscope®  probes were detected in cryostat sections and 
imaged via either confocal (panels A,C) or brightfield (panel B) microscopy. Within the inner ear, dashed lines indicate 
the epithelial layers. Double-labeling of Axl (green) and anti-myosin-6 (red) is shown in panels A,C; in these confocal 
images, pseudocoloring of Axl as a green signal offered better clarity. All higher power images of the cochlear duct are 
shown with the center of the cochlear spiral (called medial) to the left. (A) The E12.5 cochlear duct is shown as a maximum-
intensity Z-projection of 23 confocal image slices (approximately 20 microns of depth). By enhancing the contrast, Axl 
expression can be observed throughout the thick prosensory domain (psd), the thin non-sensory roof and the surrounding 
mesenchyme (mes). Scale bar = 50 microns. (B) At E15.5, Axl (pink) is expressed in the cochlear duct, but with an obvious 
gap of reduced Axl expression (arrowhead) that was reproducibly observed midway along the floor of the duct. The roof 
has partly collapsed onto itself. Scale bar = 50 microns. (C) Low power view of a single confocal slice through the E18.5 
inner ear with the cochlea in the top half and 3 vestibular organs in the bottom half. Cross-sections through the spiral 
ganglion are outlined in solid green. The auditory nerve (AN) exits the cochlea and will enter the brain (removed at 
dissection) at the Schwann-glial border (sgb). Single confocal slices of the boxed areas are shown at higher power. Axl 
(green) is present in nearly all of the epithelial and mesenchymal tissues of the cochlea, except as noted in the text. At least 
some hair cells and supporting cells appear to express Axl in all inner ear sensory organs. Hair cell expression of Axl is 
shown at higher power in panel C1a. Scale bars: C = 200 microns; C1, C2, C3 = 20 microns; C1b = 5 microns. Abbreviations: 
AN, auditory nerve; bm, basilar membrane; ca, crista ampullaris; cc, cochlear capsule; cd, cochlear duct; GER, greater 
epithelial ridge; hcl, hair cell layer; ihc, inner hair cell; mes, mesenchyme; oC, organ of Corti; ohcs, outer hair cells; os, 
outer sulcus; psd, prosensory domain; Rm, Reissner’s membrane; sac, saccular macula; scl, supporting cell layer; sgb, 
Schwann-glial border; sm, scala media; SpG, spiral ganglion; stria, stria vascularis; um, utricular macula. 
By E15.5, the floor of the cochlear duct showed a reproducible gap in Axl expression 
(Figure 5B, black arrowhead). This gap was associated with the position of the developing 
organ of Corti, as indicated by double-staining with antibody to myosin-6 (shown at E18.5 
in Figure 5C1). Both inner and outer hair cells and their associated supporting cells were 
located within the gap. We used confocal imaging of E18.5 specimens to address whether 
Figure 5. xl is expressed in the embryonic mouse cochlea. R scope® robes ere etecte i cryostat sectio s and
i aged via either confocal (panels A,C) or brightfield (panel B) microscopy. With n the inner ear, dashed lines indicate the
epithel al layers. Double-la ling of Axl (green) and anti-myos n-6 (red) is shown in (pa els A,C); in these confocal images,
pseudocoloring of Axl as a green signal offered better clarity. All higher power images of the cochlear duct are shown with
the center of the cochlear spiral (called medial) to the left. (A) The E12.5 cochlear duct is shown as a maximum-intensity
Z-projection of 23 confocal image slices (approximately 20 microns of depth). By enhancing the contrast, Axl expression can
be observed throughout the thick prosensory domain (psd), the thin non-sensory roof and the surrounding mesenchyme
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The organ of Corti can be contrasted with higher Axl expression in the epithelial cells
of the GER that flank the organ on its medial side and the outer sulcus that flank its lateral
side (Figure 5(C1)). Most cells of the GER and the outer sulcus become post-mitotic 2–4
days after the organ of Corti in the mouse [19]. A large fraction of GER cells will disappear
by postnatal day 14 through autophagy [35] and apoptosis [36].
The spiral ganglion, where the cell bodies of the primary sensory neurons of the
cochlea are located, appears to have an intermediate level of Axl expression (Figure 5C)
when compared to the otic capsule (negative) or the strong positive signals in the cochlear
mesenchyme within the cochlea. Strong mesenchymal signals include the tissue in the
center of the cochlea (Figure 5C) and the cells beneath the epithelium on the roof (Reissner’s
membrane anlage), the basilar membrane and the lateral wall (stria vascularis anlage) of
the cochlear duct (Figure 5(C1)).
A high level of Axl expression at E18.5 was observed in cells dispersed within the
auditory nerve as it travels through the cochlea (Figure 5C). We presume Axl was expressed
by Schwann cells and/or fibroblasts in the peripheral part of this nerve, because there was
an abrupt decrease in Axl levels precisely where the auditory nerve entered the central
nervous system at the Schwann-glial border (Figure 5C). Here the Schwann cells and fibrob-
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lasts give way to oligodendrocytes and astrocytes as the auditory nerve enters the brain. In
contrast to these examples, the cartilage cells of the otic capsule are consistently low in Axl
expression (Figure 5C). The hair cell and supporting cell layers of the vestibular organs
(utricular macula, saccular macula, crista ampullaris) showed scattered Axl expression on
E18.5 (Figure 5(C2,C3)); we did not examine the vestibular organs at P2.
4. Discussion
In this study, cochlear explants derived from Swiss Webster mice were used to evaluate
ZIKV tropism for the sensory organ of hearing. Unlike in vivo mouse studies which
required genetic strains with compromised interferon signaling to evade the immune
response, we show that cochlear explants were susceptible to ZIKV in a wild-type strain.
In a recent study, ZIKV readily infected inner ear tissues lacking a type I interferon receptor
following a systemic route of virus delivery (foot pad injections) in adult ifnar1−/− mice [10].
Our study thus fills in a developmental gap, revealing ZIKV susceptibility at a mitotic
stage of organogenesis and extending that to the early postnatal period, when the organ
of Corti is post-mitotic. These stages approximately correspond to the first 4 months of
human embryogenesis. In humans, the prosensory cochlea is postmitotic at 10 weeks of
gestation, hair cells begin to appear at 12 weeks and the full complement of hair cells is
present in the middle turn at 15 weeks [37,38].
The penetrance of hearing loss associated with Congenital ZIKV Syndrome varies
widely across studies (reviewed by [4]). One retrospective study that examined 69 infants
presenting with microcephaly indicated a 6% penetrance within the first 10 months after
birth using ABR as a screening tool [39]. Overall, studies using ABR screens detected
hearing loss in 0–29% of infants with presumed or verified ZIKV exposure in utero [4].
Using OAE as a screening tool, ZIKV exposure correlated with hearing loss in 0–75% of
infants [4]. It remains to be determined why there is such high variability in penetrance
of hearing loss between studies, although this could result from differences in inclusion
criteria of the subjects. High variability of ZIKV infection in the brain and inner ear of
chicken embryos was evident in previous studies from our laboratory [9,40]. Similarly, we
observed considerable differences in the overall amount of ZIKV infection across samples
in this study, even when comparing within a single experiment. It is not known how much
of this variability might be due to experimental conditions (such as virus draining away
from some explants). Despite this variability, overall, we have confirmed that direct ZIKV
infection of the embryonic mammalian hearing organ is possible and might underlie at
least some of the hearing deficits found in human infants exposed to ZIKV in utero.
One unexpected finding was that ZIKV infection did not significantly increase cell
death in either the organ of Corti or the GER. In the central nervous system of chicken
embryos, regions with high levels of ZIKV infection were shown to overlap with excessive
levels of cell death within 3 days of exposure to the virus in ovo [40]. Likewise, in this
same species, infection of the embryonic statoacoustic ganglion of the inner ear caused
a marked shrinkage of this structure, which we speculate was caused by increased cell
death observed a few days earlier [9]. On the other hand, infected sensory organs of the
embryonic chicken inner ear appeared resistant to the pathological effects of ZIKV. Results
differed in the Ifnar1−/− mouse cochlea infected with ZIKV at 5–6 weeks of age. In this
model, ZIKV infection led to cellular pathologies in the inner ear 9 days after systemic
delivery of the virus [10]. Readouts of the cell death effectors such as active Caspase-3 were
not evaluated, although other cellular proteins associated with stress were abnormally
increased. In the current study, neither quantitative analysis of active Caspase-3 after 3 days
nor morphological assessment after 6 days revealed pathological changes in the cochlear
epithelium due to ZIKV infection. Since we did not include physiological assessment
of organ explants, we have no information on possible functional consequences of an
ongoing ZIKV infection in vitro. Perhaps a longer survival time is needed for pathologies
to manifest, or perhaps the embryonic ages and/or genetic backgrounds may explain the
difference in outcome for this study, when compared to that of Ifnar1−/− adult mice [10].
Viruses 2021, 13, 1823 14 of 17
Alternatively, the embryonic hearing organ may be able to harbor ZIKV without detrimental
consequences. If this finding could be confirmed and extended to humans, it may help
to explain why hearing loss associated with inner ear pathophysiology, as indicated by
reduced otoacoustic emissions, is a comorbidity for only a minority of patients with
congenital ZIKV syndrome [39].
Our results showed that addition of a well-characterized neutralizing antibody [12]
that binds to the envelope proteins of ZIKV [24] was effective in blocking ZIKV from estab-
lishing a productive infection of cochlear explants. Presumably, the antibody interfered
with the binding of ZIKV to the host cell receptor(s). The delivery of mRNA encoding this
monoclonal antibody is currently being explored as a protective treatment against ZIKV
infection, with initial experiments conducted in mice [14].
We examined the spatiotemporal pattern of Axl expression in the developing cochlea
to determine whether its distribution overlapped with ZIKV susceptibility. We initiated this
line of inquiry because of data showing that AXL can promote the entry and/or replication
of flaviviruses in other tissues and organs (reviewed by [16]). AXL has at least two modes of
action to enhance flavivirus infection of cultured cells: (1) its extracellular domain facilitates
virus attachment using the GAS6 ligand as a bridge between the host cell and the virus
membrane and (2) its intracellular kinase activity boosts viral production by muting type
I interferon signaling to reduce the cellular antiviral response [27,29,41]. Axl expression
correlates with permissiveness to ZIKV in many human host cells, including skin cells [28],
neural progenitors and embryonic astrocytes and microglia [26,27]. However, AXL is
unlikely to be the sole attachment factor for ZIKV based on results from AXL deficiency in
mammalian cell lines [29,42]. A similar conclusion was reached for mice in vivo, because
brains, eyes and testes retained their susceptibility to ZIKV infection in AXL-deficient
mice [25,43–45]. Likewise, ZIKV-mediated pathology was not prevented in neonatal Axl-
knockout mice [45]. Moreover, a positive correlation between ZIKV permissivity and
Axl expression in the brains of newborn mice is evident in only some, but not all, brain
regions [45].
The ubiquitous expression of Axl in the E12.5 embryonic cochlea overlaps with a broad
tropism observed for ZIKV at this age, but this correspondence weakens as the sensory
primordium pulls out of division between E12.5 and E14.5. By E15.5 and continuing
into the early postnatal period, Axl transcripts are significantly reduced in both hair cells
and supporting cells of the developing organ of Corti, and yet, these cells retain at least
moderate susceptibility to infection by ZIKV delivered to cochlear explants. This suggests
that for the cells of the organ of Corti, like many other tissues in the mouse, AXL may not
be an exclusive cell surface protein mediating ZIKV attachment.
The global threat to human health posed by pathogenic flaviviruses is likely to con-
tinue for the foreseeable future [46], necessitating further progress in understanding virus-
induced pathologies. ZIKV now joins several pathogens whose exposure to the gestating
fetus correlates with congenital hearing loss after birth [47,48]. Knowing whether infection
of the peripheral auditory system in utero could underlie some aspects of the ensuing
hearing loss is necessary for choosing appropriate therapeutic treatments. One strategy to
reveal viral tropism in relatively inaccessible tissues with complex cytoarchitectures, such
as the embryonic inner ear, is demonstrated in this study through the use of organ cultures
in animal models.
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